330 related articles for article (PubMed ID: 17251316)
1. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community.
Armour C; Bosnic-Anticevich S; Brillant M; Burton D; Emmerton L; Krass I; Saini B; Smith L; Stewart K
Thorax; 2007 Jun; 62(6):496-502. PubMed ID: 17251316
[TBL] [Abstract][Full Text] [Related]
2. Intern pharmacists as change agents to improve the practice of nonprescription medication supply: provision of salbutamol to patients with asthma.
Schneider CR; Everett AW; Geelhoed E; Padgett C; Ripley S; Murray K; Kendall PA; Clifford RM
Ann Pharmacother; 2010; 44(7-8):1319-26. PubMed ID: 20571101
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of a community pharmacy-based rural asthma management service.
Saini B; Filipovska J; Bosnic-Anticevich S; Taylor S; Krass I; Armour C
Aust J Rural Health; 2008 Apr; 16(2):100-8. PubMed ID: 18318852
[TBL] [Abstract][Full Text] [Related]
4. The sustainability of a community pharmacy intervention to improve the quality use of asthma medication.
Bereznicki B; Peterson G; Jackson S; Walters EH; Gee P
J Clin Pharm Ther; 2011 Apr; 36(2):144-51. PubMed ID: 21366642
[TBL] [Abstract][Full Text] [Related]
5. Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial.
Armour CL; Reddel HK; LeMay KS; Saini B; Smith LD; Bosnic-Anticevich SZ; Song YJ; Alles MC; Burton DL; Emmerton L; Stewart K; Krass I
J Asthma; 2013 Apr; 50(3):302-9. PubMed ID: 23270495
[TBL] [Abstract][Full Text] [Related]
6. Measuring the assessment and counseling provided with the supply of nonprescription asthma reliever medication: a simulated patient study.
Schneider CR; Everett AW; Geelhoed E; Kendall PA; Clifford RM
Ann Pharmacother; 2009 Sep; 43(9):1512-8. PubMed ID: 19690228
[TBL] [Abstract][Full Text] [Related]
7. Development, implementation, and evaluation of a community pharmacy-based asthma care model.
Saini B; Krass I; Armour C
Ann Pharmacother; 2004 Nov; 38(11):1954-60. PubMed ID: 15479780
[TBL] [Abstract][Full Text] [Related]
8. Uptake and effectiveness of a community pharmacy intervention programme to improve asthma management.
Bereznicki BJ; Peterson G; Jackson S; Walters EH; George J; Stewart K; March GJ
J Clin Pharm Ther; 2013 Jun; 38(3):212-8. PubMed ID: 23437933
[TBL] [Abstract][Full Text] [Related]
9. Implementation of asthma guidelines to West Australian community pharmacies: an exploratory, quasi-experimental study.
Watkins K; Trevenen M; Murray K; Kendall PA; Schneider CR; Clifford R
BMJ Open; 2016 Aug; 6(8):e012369. PubMed ID: 27580836
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of pharmacist intervention for asthma control improvement.
Mehuys E; Van Bortel L; De Bolle L; Van Tongelen I; Annemans L; Remon JP; Brusselle G
Eur Respir J; 2008 Apr; 31(4):790-9. PubMed ID: 18094011
[TBL] [Abstract][Full Text] [Related]
11. Community pharmacy-based pharmaceutical care for asthma patients.
Mangiapane S; Schulz M; Mühlig S; Ihle P; Schubert I; Waldmann HC
Ann Pharmacother; 2005 Nov; 39(11):1817-22. PubMed ID: 16219893
[TBL] [Abstract][Full Text] [Related]
12. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.
Krass I; Armour CL; Mitchell B; Brillant M; Dienaar R; Hughes J; Lau P; Peterson G; Stewart K; Taylor S; Wilkinson J
Diabet Med; 2007 Jun; 24(6):677-83. PubMed ID: 17523968
[TBL] [Abstract][Full Text] [Related]
13. Effect of a pharmacist intervention on asthma control. A cluster randomised trial.
García-Cárdenas V; Sabater-Hernández D; Kenny P; Martínez-Martínez F; Faus MJ; Benrimoj SI
Respir Med; 2013 Sep; 107(9):1346-55. PubMed ID: 23810267
[TBL] [Abstract][Full Text] [Related]
14. Medication reviews in the community: results of a randomized, controlled effectiveness trial.
Sorensen L; Stokes JA; Purdie DM; Woodward M; Elliott R; Roberts MS
Br J Clin Pharmacol; 2004 Dec; 58(6):648-64. PubMed ID: 15563363
[TBL] [Abstract][Full Text] [Related]
15. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.
Bereznicki B; Peterson G; Jackson S; Haydn Walters E; DeBoos I; Hintz P
J Clin Pharm Ther; 2011 Jun; 36(3):348-55. PubMed ID: 21545614
[TBL] [Abstract][Full Text] [Related]
16. Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control.
Armour CL; Lemay K; Saini B; Reddel HK; Bosnic-Anticevich SZ; Smith LD; Burton D; Song YJ; Alles MC; Stewart K; Emmerton L; Krass I
J Asthma; 2011 Nov; 48(9):914-22. PubMed ID: 21942306
[TBL] [Abstract][Full Text] [Related]
17. A study of a multi-level intervention to improve non-adherence in difficult to control asthma.
Gamble J; Stevenson M; Heaney LG
Respir Med; 2011 Sep; 105(9):1308-15. PubMed ID: 21511454
[TBL] [Abstract][Full Text] [Related]
18. A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients.
Manfrin A; Tinelli M; Thomas T; Krska J
BMC Health Serv Res; 2017 Apr; 17(1):300. PubMed ID: 28438152
[TBL] [Abstract][Full Text] [Related]
19. A text message programme designed to modify patients' illness and treatment beliefs improves self-reported adherence to asthma preventer medication.
Petrie KJ; Perry K; Broadbent E; Weinman J
Br J Health Psychol; 2012 Feb; 17(1):74-84. PubMed ID: 22107110
[TBL] [Abstract][Full Text] [Related]
20. Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial.
De Vera MA; Sadatsafavi M; Tsao NW; Lynd LD; Lester R; Gastonguay L; Galo J; FitzGerald JM; Brasher P; Marra CA
Trials; 2014 Dec; 15():488. PubMed ID: 25494702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
